Hydrobromide salt of pridopidine
US9814706B2 · kind B2 · utility
12Cited by
21References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2015 |
| Grant date | Nov 14, 2017 |
| Priority date | — |
| Expiry date | Feb 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a new salt of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides the pharmaceutically acceptable hydrobromide salt, pharmaceutical compositions comprising this salt, and uses of this salt as a drug substance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.